Clinical Trial Contact Request

A PHASE 1, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE BLIND, SINGLE ASCENDING DOSE STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CLY-124 IN HEALTHY VOLUNTEERS AND PARTICIPANTS WITH SICKLE CELL DISEASE